News & Events
Press Release: New lung cancer research study
April 15th, 2010
Denver CyberKnife obtains IRB approval as the only site in Colorado to participate in a phase IIII lung cancer trial comparing radiosurgery to surgery
Lone Tree, CO — April 15, 2010 —...New Denver CyberKnife Article
September 30th, 2009
Denver CyberKnife Featured in Medical Products Outsourcing
Dr. Gregg Dickerson, the medical director of Denver CyberKnife was recently quoted in an article by Michael Barbella in Medical Product Outsourcing’s September 2009 issue. As a leader in radiation oncology and, more specifically, radiosurgery, Dr. Dickerson was able to provide expert information to the author.
The following (in blue) is an excerpt from the article that features CyberKnife. The full article can be accessed at: http://www.mpo-mag.com/articles/2009/09/embarking-on-a-fantastic-voyage
In 2001 (the same year Intuitive Surgical received approval for its da Vinci System), the FDA approved CyberKnife Radiosurgery for the treatment of tumors anywhere in the body. Since then, the company has received FDA approval for systems that enable doctors to track, detect and treat tumors in the lung, liver, pancreas and spine.
CyberKnife Radiosurgery is not actually a knife, but rather a radiation tool that can destroy tumors and lesions without surgery, pain, anesthesia or long recovery times. “CyberKnife [Radiosurgery] is able to accomplish an equivalent and perhaps superior treatment because it is not limited by the ability to remove critical tissues,” said Gregg A. Dickerson, M.D., F.A.C.R., and specialist in CyberKnife Radiosurgery at Denver CyberKnife, a radiation therapy center based in Colorado’s capital city. “We can radiate them. It’s a very surgical modality rather than a radiation tool. It’s more of a surgical instrument.”
CyberKnife Radiosurgery uses image guidance software to track and continually adjust treatment for any patient or tumor movement, allowing patients to breathe normally and relax comfortably during treatment. Before treatment, the patient undergoes imaging procedures (usually CT scans) to determine the size, shape and location of their tumor.
After the scanning is completed, doctors transfer the image data to the system’s workstation, where they identify the exact size, shape and location of the tumor to be treated. Doctors also identify the surrounding healthy tissue to be spared doses of radiation.
Once a treatment plan is created, the patient lies on a table for radiation treatments that last between 30 and 90 minutes. The treatment typically involves the administration of between 100 and 200 radiation beams delivered from different directions, each lasting 10 to 15 seconds. Before each beam of radiation is delivered, the CyberKnife Radiosurgery system simultaneously takes X-ray images and compares them to the original CT scan. This image-guided approach continually tracks, detects and corrects for any movement of the patient and tumor during the treatment process.
“CyberKnife Radiosurgery costs 30 percent to 50 percent less than a dose of radiation delivered the traditional way,” Dickerson noted. “It is a tremendous cost savings to the health care system. And patients love it. They don’t have complications afterward, they go on with their lives.”
Second Commercial
August 24th, 2009
Click here to view our second commercial. It will begin airing in the Denver market in the last week of August.
First Lung Case Treated in Denver
August 8th, 2009
Denver CyberKnife has successfully completed treatment on its first lung tumor patient in Denver. While Dr. Gregg Dickerson, Steve Humphries and Mark Post have all treated hundreds of patients with early-stage lung cancer, this marks completion of the first treatment in the new center in Denver. Initial results look extremely positive.
Denver CyberKnife has also received FWA approval to continue through the IRB review process, a crucial step in the ability to participate in the groundbreaking STARS protocol. This clinical study, sponsored by the MD Anderson Cancer Center in Houston, TX, is the premier radiosurgery study. The intent is to compare lung radiosurgery to traditional lung surgery for patients with early-stage lung cancer. The CyberKnife is the only device that MD Anderson deemed appropriate for use in this study. Once finalized, Denver CyberKnife will be one of the few centers in the country to provide access to this important protocol.
Commercial a Success!
July 10th, 2009
Click here to view our commercial. After running for a week, the Denver CyberKnife commercial has received rave reviews and continues to generate interest in this amazing technology.
Press Release: New Jobs Created
July 6th, 2009
Denver, CO — July 6, 2009 — Denver CyberKnife (www.DenverCK.com), the state-of-the-art treatment device for cancer and tumors throughout the body has aided the economic recovery in Denver through the creation of 8 new jobs. Denver’s first CyberKnife...New Commercial
July 2nd, 2009
The Denver, Colorado television audience will begin to see the new Denver CyberKnife commercial starting on Monday, July 6th. Click here to view it now. We are ready to help patients with brain, spine, prostate, lung, kidney, pancreas, and liver tumors.
Treating Patients, One Day at a Time
June 30th, 2009
Residents of Denver, Colorado now have a new option for treatment of tumors and cancer throughout the body. Denver CyberKnife is ready to help patients with brain, spine, prostate, lung, kidney, pancreas, and liver tumors.
If have any questions, do not hesitate to contact us.
If you are a physician and would like to have a private tour, please contact us at (303) 396-1414 to set up a time that works for your schedule.
